Response to: The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury

por Simmon, Vincent F
Publicado 2009

Detection of perillyl alcohol and its metabolite perillic acid in postsurgical glioblastoma tissue after intranasal administration of NEO100: illustrative case

por Schönthal, Axel H., Swenson, Steve, Bonney, Phillip A., Wagle, Naveed, Simmon, Vincent F., Mathew, Anna J., Hurth, Kyle M., Chen, Thomas C.
Publicado 2022

Phase I trial of intranasal NEO100, highly purified perillyl alcohol, in adult patients with recurrent glioblastoma

por Schönthal, Axel H, Peereboom, David M, Wagle, Naveed, Lai, Rose, Mathew, Anna J, Hurth, Kyle M, Simmon, Vincent F, Howard, Steven P, Taylor, Lynne P, Chow, Frances, da Fonseca, Clovis O, Chen, Thomas C
Publicado 2021

SPG302 Reverses Synaptic and Cognitive Deficits Without Altering Amyloid or Tau Pathology in a Transgenic Model of Alzheimer’s Disease

por Trujillo-Estrada, Laura, Vanderklish, Peter W., Nguyen, Marie Minh Thu, Kuang, Run Rong, Nguyen, Caroline, Huynh, Eric, da Cunha, Celia, Javonillo, Dominic Ibarra, Forner, Stefania, Martini, Alessandra C., Sarraf, Stella T., Simmon, Vincent F., Baglietto-Vargas, David, LaFerla, Frank M.
Publicado 2021